Identification and Testing Of Novel Cancer-Restricted Targets and their TCRS to Develop Safe and Effective T-Cell Treatment

Time: 12:00 pm
day: Day One


  • To fully exploit the therapeutic potential of TCR-T cells, we use our platform to:
  • Limit toxicity attributed to recognition of identical or highly similar targets outside cancers
  • Deliver shared intracellular targets that are cancer-selective to treat large cohorts of patients
  • Counteract the immune-suppressive nature of tumor microenvironments